Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-43,600
Closed -$1.09M 3165
2025
Q4
$1.09M Buy
43,600
+3,900
+10% +$98.3K ﹤0.01% 1731
2025
Q3
$1.01M Buy
39,700
+4,700
+13% +$116K ﹤0.01% 1838
2025
Q2
$848K Sell
35,000
-50,000
-59% -$1.17M ﹤0.01% 1892
2025
Q1
$2.15M Buy
85,000
+41,900
+97% +$1.1M ﹤0.01% 1378
2024
Q4
$1.14M Buy
+43,100
New +$1.17M ﹤0.01% 1746

Other funds holding PFE

PEAK6's PFE Position: Q1 2026 in Review

PEAK6 sold out of Pfizer (PFE) in Q1 2026, closing a stake of 22,428 shares — an estimated $558K sold.

PEAK6 first reported a position in PFE in Q4 2024 and held it in 5 quarters. The position peaked at $558K in Q4 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • PEAK6 reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • PEAK6 sold 22,428 Pfizer shares in Q1 2026, an estimated $558K.
  • PEAK6 first reported a position in Pfizer in Q4 2024 and held it in 5 quarters.
  • PEAK6's Pfizer position peaked at $558K in Q4 2025.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on PEAK6's 13F filing for Q1 2026, filed 14 May 2026.